103
Views
6
CrossRef citations to date
0
Altmetric
Review

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives

&
Pages 1-9 | Published online: 22 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kavita Kumari Kakarala & Kaiser Jamil. (2022) Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approach. Journal of Biomolecular Structure and Dynamics 40:15, pages 6889-6909.
Read now

Articles from other publishers (5)

Congying Gao, Lei Zhang, Yun Xu, Xiangyu Ma, Peilei Chen, Zhe-Sheng Chen & Liuya Wei. (2023) I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition. Frontiers in Pharmacology 14.
Crossref
Honglan Qian, Dongxu Gang, Xiaoyu He & Songfu Jiang. (2022) A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia. Frontiers in Oncology 12.
Crossref
Kazuya Sumi, Kenji Tago, Yosuke Nakazawa, Kyoko Takahashi, Tomoyuki Ohe, Tadahiko Mashino & Megumi Funakoshi-Tago. (2022) A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells. European Journal of Pharmacology 916, pages 174714.
Crossref
David Baker, Charalambos Hadjicharalambous, Sharmilee Gnanapavan & Gavin Giovannoni. (2021) Can rheumatologists stop causing demyelinating disease?. Multiple Sclerosis and Related Disorders 53, pages 103057.
Crossref
Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini, Silvia Buonamici, Simona Cotesta, Sandra W. Cowan-Jacob, Stephanie Dodd, Peter Drueckes, Doriano Fabbro, Tobias Gabriel, Jean-Marc Groell, Robert M. Grotzfeld, A. Quamrul Hassan, Chrystèle Henry, Varsha Iyer, Darryl Jones, Franco Lombardo, Alice Loo, Paul W. Manley, Xavier Pellé, Gabriele Rummel, Bahaa Salem, Markus Warmuth, Andrew A. Wylie, Thomas Zoller, Andreas L. Marzinzik & Pascal Furet. (2018) Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. Journal of Medicinal Chemistry 61:18, pages 8120-8135.
Crossref